About
Novel antibiotics, antifungals, and treatments for certain cancers and dermatological conditions
Areas of Focus
Categories
Small Molecule Pharmaceutical
Clinical Trials (10)
View allTotal Trials
10
As Lead Sponsor
9
As Collaborator
1
Total Enrollment
1,133
By Phase
PHASE2: 2PHASE3: 1PHASE1: 4PHASE1/PHASE2: 3
By Status
RECRUITING: 4NOT_YET_RECRUITING: 3UNKNOWN: 2ACTIVE_NOT_RECRUITING: 1
Clinical Trials Pipeline10 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2022
2023
2024
2025
2026
2027
2028
2029
Today
Hover over trial bars to see details
Recent Trials
NCT06072326Collaborator
dApagliflozin SC0062 and Prevention of Renal Injury; a Randomized Evaluation
PHASE2Not yet recruiting
36 participants
Started: Jan 31, 2026 · Completed: Dec 31, 2028
NCT06819826Lead Sponsor
A Study of SC0062 Capsule for the Treatment of IgA Nephropathy with Proteinuria
PHASE3Recruiting
360 participants
Started: Feb 14, 2025 · Completed: Dec 31, 2028
NCT06548672Lead Sponsor
A Study to Assess the Safety, Pharmacokinetics, and Antitumor Activity of BC3195 in Patients With Advanced or Metastatic Cancer
PHASE1Recruiting
148 participants
Started: Jun 24, 2024 · Completed: Jun 30, 2027
NCT06111326Lead Sponsor
BC3402 in Combination With Durvalumab in Patients With Advanced Hepatocellular Carcinoma
PHASE1/PHASE2Not yet recruiting
83 participants
Started: Oct 31, 2023 · Completed: May 31, 2026
NCT06055348Lead Sponsor
SC0191 Plus Chemotherapy in Advanced Ovarian Canceradvanced Ovarian Cancer
PHASE1/PHASE2Not yet recruiting
112 participants
Started: Oct 30, 2023 · Completed: Nov 30, 2025
Locations (1)
Headquarters
North Vancouver, BC, Canada
Map
Loading map...